| 1 |
Fatty Acid Conjugated Chalcones as Tubulin Polymerization Inhibitors: Design, Synthesis, QSAR, and Apoptotic and Antiproliferative Activity |
26/4/2023 |
| 2 |
Nature-inspired chalcone-functionalized paracetamol derivatives as potential anticancer leads: synthesis, biological evaluation, apoptotic mechanisms, and in silico docking studies |
2026 |
| 3 |
Analysis of CD22 cis-ligands using a synthetic sialoside binding to CD22 with ultra-high affinity |
2025 |
| 4 |
CDK2 Inhibitors: Rationally Directed Discovery of a Novel Potent Lead derived from Cyclohepta[e]thieno[2,3-b]pyridine |
2025 |
| 5 |
Design, synthesis, and antiproliferative activity of new 5-ethylsulfonylindazole- 3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors |
2025 |
| 6 |
Design, Synthesis, and Antiproliferative Activity of Novel Indole/1,2,4-Triazole Hybrids as Tubulin Polymerization Inhibitors |
2025 |
| 7 |
Design, synthesis, antimalarial activity, and in-silico studies of new benzimidazole/pyridine hybrids as dihydrofolate reductase inhibitors |
2025 |
| 8 |
Design, Synthesis, Biological Evaluation, and In Silico Studies of New Nitazoxanide Derivatives: Toward Broad‐Spectrum Antimicrobial Agents |
2025 |
| 9 |
Exploring the antitrypanosomal potential of rosemary root endophytic fungi with metabolomic profiling and molecular docking insights |
2025 |
| 10 |
Further insights into the multitarget anticancer activity of tetrahydrocarbazole-1-amine/5-arylidene-4-thiazolinone based hybrids |
2025 |
